TRHC - Tabula Rasa HealthCare Schedules First Quarter 2022 Earnings Conference Call

PR Newswire

MOORESTOWN, N.J. , April 21, 2022 /PRNewswire/ -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), will hold a conference call and webcast to discuss its first quarter 2022 operating results Friday, May 6, 2022 at 8:30 a.m. EDT . The conference call will be hosted by TRHC CEO, Chairman and Founder, Calvin H. Knowlton, Ph.D.; TRHC Co-Founder and President, Orsula V. Knowlton , PharmD, MBA; TRHC President, Brian W. Adams ; and TRHC Chief Financial Officer, Thomas Cancro. The Company's financial results for the first quarter ended March 31, 2022 , will be released after the close of the market Thursday, May 5, 2022 .

For a live audio webcast of the call, please visit the Investor Relations section of TRHC's website ( ir.tabularasahealthcare.com ). To listen to the conference call please dial 844-413-0947, or 216-562-0423 for international callers, and reference conference ID 6119738 approximately 15 minutes prior to the call.

To listen to a replay of the conference call, available for 7 days, please dial 855-859-2056, or 404-537-3406 for international callers, and reference conference ID 6119738. An audio file of the call also will be archived at ir.tabularasahealthcare.com and available for replay approximately two hours after the live event for a period of 90 days.

About Tabula Rasa HealthCare
Tabula Rasa HealthCare (TRHC) provides medication safety solutions that empower healthcare professionals and consumers to optimize medication regimens, combatting medication overload and reducing adverse drug events– the fourth leading cause of death in the US. TRHC's proprietary technology solutions, including MedWise®, improve patient outcomes, reduce hospitalizations, and lower healthcare costs. TRHC's extensive clinical tele-pharmacy network improves care for patients nationwide. Its solutions are trusted by health plans and pharmacies to help drive value-based care. For more information, visit TRHC.com .

SOURCE Tabula Rasa HealthCare, Inc.